Antagonisation of Prokineticin Receptor‐2 Attenuates Preeclampsia Symptoms
Journal of Cellular and Molecular Medicine · 2025-01 · 29 (2)
DOI: 10.1111/jcmm.70346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 16.01.2025. Verfasst von Frédéric Sergent und 13 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Institute of Grenoble, IRIG-Biosanté, University Grenoble Alpes, INSERM, CEA, UMR 1292, Grenoble, France. Hauptthemen laut MEDLINE: Pre-Eclampsia, Receptors, G-Protein-Coupled, Receptors, Peptide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Groupement des Entreprises Françaises dans la lutte contre le Cancer, University Grenoble-Alpes, GRAL.
Abstract (Originalsprache)
Preeclampsia (PE) is the most threatening pathology of human pregnancy. Placenta from PE patients releases harmful factors that contribute to the exacerbation of the disease. Among these factors is the prokineticin1 (PROK1) and its receptor, PROKR2 that we identified as a mediators of PE. Here we tested the effects of PKRA, an antagonist of PROKR2, on the attenuation of PE symptoms. We used the genetic PE mouse model, STOX1 that overexpresses Stox1 gene in a heterozygosis manner in the placenta. This model allowed exploiting two genotypes of the offspring, those that overexpress the Stox1 gene, and the WT that grow in a PE environment (STE). We characterised the effect PKRA (1 μM) on the attenuation of PE symptoms and compared its effects on STOX1 and STE placentas. We also used STOX1 overexpressing trophoblast cells to decipher the PROK1‐underlying mechanism. We demonstrated that (i) antagonisation of PROKR2 attenuated PE‐mediated hypertension and proteinuria, (ii) STE placentas and foetuses exhibited better outcomes in response to PKRA, (iii) the secretome of STOX1‐trophoblasts impacted the integrity of the fetal vasculature that was attenuated by PKRA treatment. This study demonstrates the direct involvement of the PROK1 in PE and identifies PKRA as a promising therapy for PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Research Institute of Grenoble, IRIG-Biosanté, University Grenoble Alpes, INSERM, CEA, UMR 1292, Grenoble, France.
- Commissariat à l'Energie Atomique et Aux Energies Alternatives (CEA), Biosciences and Biotechnology Institute of Grenoble, Grenoble, France.
- Institute Cochin, U1016, INSERM, UMR 8504 CNRS, Paris-Descartes Université, Paris, France.
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies Pour la Santé (DMTS), Gif-sur-Yvette, France.
- Centre Hospitalo-Universitaire Grenoble Alpes, Service Obstétrique, CS 10217, Grenoble, France.
- Université Grenoble Alpes, Grenoble, France.
ORCID-Profile: Trinh-Le-Vi Kieu, Nadia Alfaidy
Förderung
- Fondation pour la Recherche Médicale
- Groupement des Entreprises Françaises dans la lutte contre le Cancer
- University Grenoble-Alpes, GRAL
- Inserm Transfert
- INSERM U1292
Zitieren
APA
Sergent, F., Vaiman, D., Raia-Barjat, T., Younes, H., Marquette, C., Desseux, M., Nahed, R. A., Kieu, T. L., Dung, N. V., Keck, M., Hoffmann, P., Murthi, P., Benharouga, M., & Alfaidy, N. (2025). Antagonisation of Prokineticin Receptor‐2 Attenuates Preeclampsia Symptoms. Journal of Cellular and Molecular Medicine, 29(2). https://doi.org/10.1111/jcmm.70346
Vancouver
Sergent F, Vaiman D, Raia-Barjat T, Younes H, Marquette C, Desseux M, et al. Antagonisation of Prokineticin Receptor‐2 Attenuates Preeclampsia Symptoms. Journal of Cellular and Molecular Medicine. 2025;29(2). doi:10.1111/jcmm.70346
BibTeX
@article{Sergent2025,
author = {Sergent, Frédéric and Vaiman, Daniel and Raia-Barjat, Tiphaine and Younes, Hadi and Marquette, Christel and Desseux, Morgane and Nahed, Roland Abi and Kieu, Trinh-Le-Vi and Dung, Nguyen Viet and Keck, Mathilde and Hoffmann, Pascale and Murthi, Padma and Benharouga, Mohamed and Alfaidy, Nadia},
title = {Antagonisation of Prokineticin Receptor‐2 Attenuates Preeclampsia Symptoms},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {2},
doi = {10.1111/jcmm.70346}
}
EUVIMED